Table 2.
2013/2014 | 2014/2015 | 2015/2016 | 2016/2017 | All seasons | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Controls | Patients | Controls | P‐value | Patients | Patients | Controls | P‐value | Patients | Controls | P‐value | |
Number of tests | n = 215 | n = 98 | n = 228 | n = 265 | n = 63 | n = 84 | n = 426 | n = 549 | |||
Positive samples | 9 (4%) | 27 (28%) a | 13 (5%) | <.001 | 31 (12%) b | 12 (19%) d | 10 (12%) | .24 | 70 (16%) c | 32 (6%) | <.001 |
Number of viruses | 9 | 34 | 13 | <.001 | 34 | 15 | 10 | .06 | 83 | 32 | <.001 |
Viruses | |||||||||||
Influenza | 0 | 1 (3%) | 4 (31%) | .03 | 5 (15%) | 0 | 0 | ‐ | 6 (9%) | 4 (13%) | .42 |
Corona | 4 (44%) | 6 (18%) | 4 (31%) | .36 | 8 (24%) | 8 (53%) | 8 (80%) | .93 | 22 (31%) | 16 (50%) | .02 |
PIV | 0 | 4 (12%) | 1 (8%) | .65 | 5 (15%) | 0 | 0 | ‐ | 9 (13%) | 1 (3%) | .09 |
hMPV | 1 (11%) | 0 | 0 | ‐ | 1 (3%) | 0 | 0 | ‐ | 1 (1%) | 1 (3%) | .56 |
RV | 3 (33%) | 3 (9%) | 2 (15%) | .55 | 7 (21%) | 2 (13%) | 1 (10%) | .80 | 12 (16%) | 6 (18%) | .59 |
RSV | 0 | 13 (38%) | 1 (8%) | .06 | 3 (9%) | 2 (13%) | 1 (10%) | .80 | 18 (26%) | 2 (6%) | .013 |
Adeno | 1 (11%) | 7 (21%) | 7 (21%) | .03 | 5 (15%) | 3 (20%) | 0 | ‐ | 15 (21%) | 2 (6%) | .05 |
Influenza: A n = 7 and B n = 3; Corona: 229E n = 18, OC43 n = 11, HKU1 n = 4 and NL63 n = 5; PIV: type 1 n = 2, type 2 n = 2, type 3 n = 6; hMPV: types A/B n = 2; RV: Rhinovirus n = 17, Enterovirus n = 1; RSV: types A/B n = 20; Adeno: n = 17.
Including 3 double‐positive and 2 triple‐positive samples accounting for 34 detected viruses,
including 3 double‐positive samples accounting for 34 viruses,
due to 6 double‐positive and 2 triple‐positive samples,
including 3 double positive samples.